Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology-Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3-Month Effects on Biomarkers of Bone Turnover
Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1359/jbmr.040715
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: salmon calcitonin, postmenopausal women, bone turnover markers, bone resorption inhibition, C-terminal telopeptide of type I collagen, osteocalcin, bone-specific alkaline phosphatase, parathyroid hormone, intestinal absorption, dose-ranging, intermittent dosing, medication adherence, osteoporosis prevention, calcium and vitamin D supplementation
Open Access status: closed
Funders: Novartis, Novartis Pharma
OpenAlex ID: W1980139145
